â€” Item 17 of 40 mY wax <q Se i @ al Lo) id lA)

: Le c
Question Id: 18695 Previous Next Full Screen Tutorial Lab Values Notes Calculator Reverse Color Text Zoom

(Choice B) For non-life-threatening conditions for which standard therapies are undesirable
or ineffective, clinicians can lend their expertise to patients regarding nonstandard therapies,
even if the clinician does not fully endorse such therapies. However, there are no
nonpharmacologic therapies that are adequate for treating mastoiditis.

(Choice C) This statement begins with an appropriate gesture of concern. However, it is
inadequate because it simply reiterates treatment recommendations and does not attempt to
provide the information needed for the patient's parents to make an informed decision.

(Choice D) Although discussion with this child's family should include the risks of untreated
mastoiditis, presenting scare tactics and worst-case scenarios is likely only to further distress
the family and inhibit rational decision-making.

(Choice E) Delayed treatment of mastoiditis is not recommended. Wasting time with
ineffective treatments will only delay having a more appropriate conversation.

Educational objective:

Patients and surrogate decision-makers often have misconceptions regarding medical
conditions and the potential risks and benefits of treatment. The initial step in counseling
patients and surrogate decision-makers regarding treatment refusal is to calmly probe their

63

Settings

End Block
